Buoyant Q2 and new targets help SocGen weather Russia blow

Buoyant Q2 and new targets help SocGen weather Russia blow

A buoyant second quarter and new three-year targets helped to boost Societe Generale’s (SOGN.PA) shares on Wednesday, as the French bank weathered a 3.3-billion-euro ($3.4 billion) hit from the sale of its Russia business.

France’s third-biggest listed bank, which is seeking a new chief executive, reported a 1.48-billion-euro loss, while analysts on average had expected a loss of more than 2 billion.

The better-than-expected result, helped by robust retail and investment banking activity, lifted SocGen’s shares 4.2% in early trading, the strongest performance in the pan-European banking index (.SX7E).

Net banking income rose just over 7 billion euros, about 600 million euros higher than expected, while operating expenses came in lower at 4.46 billion euros, the bank said, as it confirmed the launch of a 915 million euros share buyback plan.

“These are excellent results, with the good news of the share buyback and ambitious but achievable goals,” said Jerome Legras, head of research at Axiom Alternative Investments.

The group’s ROTE (Return On Tangible Equity) profitability ratio stood at 10.5% on an underlying basis. It said it was aiming for ROTE of 10% and a CET 1 capital ratio of 12% in 2025.

Among other goals set for the next three years, the bank seeks to deliver a cost-to-income ratio of 62 or below and maintain a pay-out ratio of 50% of its profits. It is aiming for average annual revenue growth of at least 3% for 2021-2025.

Quarterly revenue rose 23.3% to 1.5 billion euros in the global markets business, where equity trading activity increased by 7.5% to 833 million euros, while fixed income and currency activities increased 50% to 683 million euros.

French and international retail reported a rise in net banking income of 8.5% to 2.26 billion euros and 12.7% to 1.27 billion respectively.

In May, SocGen closed the sale of its Russian business Rosbank (ROSB.MM) to the Interros group.

The same month, CEO Frederic Oudea took investors by surprise by saying he would step down next year after running the lender for 15 years.

“There is nothing new on that front,” Oudea told journalists on a conference call, saying the decision on a new CEO was still expected for the autumn.

Speculation has so far centred around Sebastien Proto, currently merging SocGen’s retail networks in France, as well as Slawomir Krupa, head of global banking and investor solutions activities.

Jacques Ripoll, who just left Credit Agricole SA (CAGR.PA), Philippe Heim, the head of France’s postal bank, and Jean Pierre Mustier, former CEO of Italy’s UniCredit (CRDI.MI), are among former SocGen executives mentioned as potential options.

Rival BNP Paribas (BNPP.PA) reported better-than-expected profits on Friday.

($1 = 0.9819 euros)


29 thoughts on “Buoyant Q2 and new targets help SocGen weather Russia blow

  1. A secret weapon for anyone who needs content. I dont need to tell you how important it is to optimize every step in your SEO pipeline. But unfortunately, its nearly impossible to cut out time or money when it comes to getting good content. At least thats what I thought until I came across Article Forge. Built by a team of AI researchers from Stanford, MIT, Carnegie Mellon, Harvard, Article Forge is an AI content writer that uses deep learning models to research, plan out, and write entire articles about any topic with the click of a button. Their team trained AI models on millions of articles to teach Article Forge how to draw connections between topics so that each article it writes is relevant, interesting and useful. All their hard work means you just enter a few keywords and Article Forge will write a complete article from scratch making sure every thought flows naturally into the next, resulting in readable, high quality, and unique content. Put simply, this is a secret weapon for anyone who needs content. I get how impossible that sounds so you need to see how Article Forge writes a complete article with the Click Here:👉 https://stanford.io/3X1mEcm

  2. Comprehensive side effect and adverse reaction information. safe and effective drugs are available.
    ivermectin buy
    Best and news about drug. Read information now.

  3. What side effects can this medication cause? earch our drug database.
    stromectol cream
    Actual trends of drug. drug information and news for professionals and consumers.

  4. Top 100 Searched Drugs. Comprehensive side effect and adverse reaction information.
    ivermectin 6
    Definitive journal of drugs and therapeutics. Read here.

  5. Definitive journal of drugs and therapeutics. Comprehensive side effect and adverse reaction information.
    ivermectin 200mg
    Some are medicines that help people when doctors prescribe. safe and effective drugs are available.

Leave a Reply

Your email address will not be published. Required fields are marked *